{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:24:04Z","timestamp":1792221844155,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00296-020-04636-y","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T13:02:43Z","timestamp":1593090163000},"page":"7-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-7018","authenticated-orcid":false,"given":"Mehmet","family":"Soy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-7461","authenticated-orcid":false,"given":"Pamir","family":"Atag\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7876-6896","authenticated-orcid":false,"given":"I\u015f\u0131k","family":"Atag\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-0029","authenticated-orcid":false,"given":"G\u00fclsan T\u00fcrk\u00f6z","family":"Sucak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"issue":"9927","key":"4636_CR1","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/s0140-6736(13)61048-x","volume":"383","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, Khamashta MA, Bosch X (2014) Adult haemophagocytic syndrome. Lancet 26 383(9927):1503\u20131516. https:\/\/doi.org\/10.1016\/s0140-6736(13)61048-x","journal-title":"Lancet 26"},{"key":"4636_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","volume":"13","author":"H Al-Samkari","year":"2018","unstructured":"Al-Samkari H, Berliner N (2018) Hemophagocytic lymphohistiocytosis. Annu Rev Pathol 13:27\u201349. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043625","journal-title":"Annu Rev Pathol"},{"key":"4636_CR3","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","volume":"118","author":"MB Jordan","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL (2011) How I treat hemophagocytic lymphohistiocytosis. Blood. 118:4041\u20134052. https:\/\/doi.org\/10.1182\/blood-2011-03-278127","journal-title":"Blood."},{"key":"4636_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/ped.13064","volume":"58","author":"A Morimoto","year":"2016","unstructured":"Morimoto A, Nakazawa Y, Ishii E (2016) Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management. Pediatr Int 58:817\u2013825. https:\/\/doi.org\/10.1111\/ped.13064","journal-title":"Pediatr Int"},{"key":"4636_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-22094-5_1","volume-title":"Cytokine storm syndrome","author":"GE Janka","year":"2019","unstructured":"Janka GE (2019) History of hemophagocytic lymphohistiocytosis. In: Cronand RQ, Behrens EM (eds) Cytokine storm syndrome. Springer Nature, Switzerland, pp 3\u201316"},{"key":"4636_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-030-22094-5_2","volume-title":"Cytokine storm syndrome","author":"DE Silverman","year":"2019","unstructured":"Silverman DE (2019) The history of macrophage activation syndrome in autoimmune diseases. In: Cronand RQ, Behrens EM (eds) Cytokine storm syndrome. Springer Nature, Switzerland, pp 17\u201330"},{"key":"4636_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-030-22094-5_3","volume-title":"cytokine storm syndrome","author":"M Schimuzu","year":"2019","unstructured":"Schimuzu M (2019) Clinical features of cytokine storm syndrome. In: Cronand RQ, Behrens EM (eds) cytokine storm syndrome. Springer Nature, Switzerland, pp 31\u201342"},{"key":"4636_CR8","first-page":"43","volume-title":"Cronand RQ","author":"FG Rosado","year":"2019","unstructured":"Rosado FG, Gopal P (2019) Laboratory features and pathology of the cytokine storm syndrome. In: Behrens EM (ed) Cronand RQ. Springer Nature, Switzerland, pp 43\u201360"},{"key":"4636_CR9","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1182\/blood.V89.11.4100","volume":"89","author":"Y Osugi","year":"1997","unstructured":"Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y et al (1997) Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 89:4100\u20134103","journal-title":"Blood"},{"issue":"10229","key":"4636_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/s0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley D, Brown M, Sanchez E, Tattersall RS, Manson J (2020) COVID-19: consider cytokine storm syndrome and immunosuppression. Lancet 395(10229):1033\u20131034. https:\/\/doi.org\/10.1016\/s0140-6736(20)30628-0","journal-title":"Lancet"},{"issue":"2","key":"4636_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","volume":"38","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M (2020) COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol 38(2):337\u2013342","journal-title":"Clin Exp Rheumatol"},{"key":"4636_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","volume":"10","author":"CB Crayne","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ (2019) The immunology of macrophage activation syndrome. Front Immunol 10:119. https:\/\/doi.org\/10.3389\/fimmu.2019.00119(eCollection 2019)","journal-title":"Front Immunol"},{"issue":"5","key":"4636_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/BOR.0000000000000093","volume":"26","author":"LK Weaver","year":"2014","unstructured":"Weaver LK, Behrens EM (2014) Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Curr Opin Rheumatol 26(5):562\u2013569. https:\/\/doi.org\/10.1097\/BOR.0000000000000093","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"4636_CR14","doi-asserted-by":"publisher","first-page":"188\u2013196.e4","DOI":"10.1016\/j.jaci.2015.06.048","volume":"137","author":"V Cetica","year":"2016","unstructured":"Cetica V, Sieni E, Pende D, Danesino C, De Fusco C, Locatelli F, Micalizzi C et al (2016) Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry. J Allergy Clin Immunol 137(1):188\u2013196.e4. https:\/\/doi.org\/10.1016\/j.jaci.2015.06.048","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4636_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00439-002-0841-0","volume":"112","author":"KG Ericson","year":"2003","unstructured":"Ericson KG, Fadeel B, Andersson M, Gudmundsson GH, G\u00fcrgey A, Yalman V, Janka G et al (2003) Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosis. Hum Genet 112(1):98\u201399. https:\/\/doi.org\/10.1007\/s00439-002-0841-0","journal-title":"Hum Genet"},{"issue":"1","key":"4636_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/humu.20274","volume":"27","author":"U ZurStadt","year":"2006","unstructured":"ZurStadt U, Beutel K, Kolberg S, Schneppenheim R, Kabisch H, Janka G, Hennies HC (2006) Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat 27(1):62\u201368. https:\/\/doi.org\/10.1002\/humu.20274","journal-title":"Hum Mutat"},{"key":"4636_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/eji.201646686","volume":"47","author":"S Ammann","year":"2017","unstructured":"Ammann S, Lehmberg K, Zur Stadt U, Janka G, Rensing-Ehl A, Klemann C et al (2017) Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation, and repertoire. Eur J Immunol 47:364\u2013373","journal-title":"Eur J Immunol"},{"key":"4636_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jpeds.2012.11.081","volume":"162","author":"K Lehmberg","year":"2013","unstructured":"Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G (2013) Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis. J Pediatr 162:1245\u20131251. https:\/\/doi.org\/10.1016\/j.jpeds.2012.11.081","journal-title":"J Pediatr"},{"key":"4636_CR19","doi-asserted-by":"publisher","unstructured":"Strippoli R, Caiello De Benedetti IF (2013) Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome http:\/\/www.jrheum.org\/content\/40\/6\/761. J Rheumatol 40:761\u2013767. https:\/\/doi.org\/10.3899\/jrheum.121233","DOI":"10.3899\/jrheum.121233"},{"key":"4636_CR20","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/rheumatology\/ken342","volume":"47","author":"S Fukaya","year":"2008","unstructured":"Fukaya S, Yasuda S, Hashimoto T, Kataoka H, Horita T, Atsumi T, Koike T (2008) Clinical features of hemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 47:1686\u20131691. https:\/\/doi.org\/10.1093\/rheumatology\/ken342","journal-title":"Rheumatology (Oxford)"},{"key":"4636_CR21","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1136\/ard.2005.046904","volume":"65","author":"JB Arlet","year":"2006","unstructured":"Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, Piette JC (2006) Reactive haemophagocytic syndrome in adult-onset Still\u2019s disease: a report of six patients and a review of the literature. Ann Rheum Dis 65:1596\u20131601","journal-title":"Ann Rheum Dis"},{"key":"4636_CR22","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1038\/ng.3089","volume":"46","author":"SW Canna","year":"2014","unstructured":"Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y et al (2014) An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 46:11406. https:\/\/doi.org\/10.1038\/ng.3089","journal-title":"Nat Genet"},{"key":"4636_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/key006","volume":"58","author":"SJ Carter","year":"2019","unstructured":"Carter SJ, Tattersall RS, Ramanan AV (2019) Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis, and treatment. Rheumatology 58:5\u201317. https:\/\/doi.org\/10.1093\/rheumatology\/key006","journal-title":"Rheumatology"},{"issue":"8","key":"4636_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jama.2020.0757","volume":"323","author":"CI Paules","year":"2020","unstructured":"Paules CI, Marston HD, Fauci AS (2020) Coronavirus infections\u2014more than just the common cold. JAMA 323(8):707\u2013708. https:\/\/doi.org\/10.1001\/jama.2020.0757","journal-title":"JAMA"},{"issue":"10223","key":"4636_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"4636_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05073-9","author":"DP Misra","year":"2020","unstructured":"Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-020-05073-9","journal-title":"Clin Rheumatol"},{"key":"4636_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/gene.2012.3","volume":"13","author":"A Ravelli","year":"2012","unstructured":"Ravelli A, Grom AA, Behrens E, Cron RQ (2012) Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology, and treatment. Genes Immun 13:289\u2013298. https:\/\/doi.org\/10.1038\/gene.2012.3","journal-title":"Genes Immun"},{"issue":"9","key":"4636_CR28","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G (2014) Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66(9):2613\u20132620. https:\/\/doi.org\/10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"4636_CR29","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1097\/CCM.0000000000001878","volume":"44","author":"S Grang\u00e9","year":"2016","unstructured":"Grang\u00e9 S, Buchonnet G, Besnier E, Artaud-Macari E, Beduneau G et al (2016) The use of ferritin to identify critically ill patients with secondary hemophagocytic lymphohistiocytosis. Crit Care Med. 44(11):e1045\u2013e1053. https:\/\/doi.org\/10.1097\/CCM.0000000000001878","journal-title":"Crit Care Med."},{"key":"4636_CR30","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Dav\u00ec S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K et al (2014) Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 66:3160\u20133169. https:\/\/doi.org\/10.1002\/art.38802","journal-title":"Arthritis Rheumatol"},{"key":"4636_CR31","doi-asserted-by":"publisher","first-page":"27380","DOI":"10.5045\/kjh.2012.47.4.273","volume":"47","author":"M-M Kim","year":"2012","unstructured":"Kim M-M, Yum M-S, Choi H-W, Ko TS, Im HJ, Seo JJ et al (2012) Central nervous system (CNS) involvement is a critical prognostic factor for hemophagocytic lymphohistiocytosis. Korean J Hematol 47:27380. https:\/\/doi.org\/10.5045\/kjh.2012.47.4.273","journal-title":"Korean J Hematol"},{"key":"4636_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2014.10.012","volume":"65","author":"F Aulagnon","year":"2015","unstructured":"Aulagnon F, Lapidus N, Canet E, Galicier L, Boutboul D, Peraldi MN et al (2015) Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. Am J Kidney Dis 65:851\u2013859. https:\/\/doi.org\/10.1053\/j.ajkd.2014.10.012","journal-title":"Am J Kidney Dis"},{"key":"4636_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/s0022-3476(85)80072-x","volume":"106","author":"M Hadchouel","year":"1985","unstructured":"Hadchouel M, Prieur AM, Griscelli C (1985) Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 106:561\u2013566. https:\/\/doi.org\/10.1016\/s0022-3476(85)80072-x","journal-title":"J Pediatr"},{"key":"4636_CR34","doi-asserted-by":"publisher","first-page":"e000161","DOI":"10.1136\/rmdopen-2015-000161","volume":"2","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A et al (2016) Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open 2:e000161. https:\/\/doi.org\/10.1136\/rmdopen-2015-000161(eCollection 2016)","journal-title":"RMD Open"},{"key":"4636_CR35","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A et al (2016) 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation collaborative initiative. Ann Rheum Dis 75:481\u2013489. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208982","journal-title":"Ann Rheum Dis"},{"key":"4636_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2020.03.001","author":"X Li","year":"2020","unstructured":"Li X, Geng M, Peng Y, Meng L, Lu S (2020) Molecular immune pathogenesis and diagnosis of COVID19. J Pharm Anal. https:\/\/doi.org\/10.1016\/j.jpha.2020.03.001","journal-title":"J Pharm Anal"},{"issue":"2","key":"4636_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, HorneA Maurizio A, Egeler RM, Filipovich AH, Imashuku S et al (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"4636_CR38","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajcp\/aqw076","volume":"145","author":"F Debaugnies","year":"2016","unstructured":"Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, Francis Corazza F (2016) Performances of the H-score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients. Am J Clin Pathol 145:862\u2013870. https:\/\/doi.org\/10.1093\/ajcp\/aqw076","journal-title":"Am J Clin Pathol"},{"key":"4636_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/03009742.2016.1167951","volume":"46","author":"ED Batu","year":"2017","unstructured":"Batu ED, Erden A, Seyhoglu E, Kilic L, Buyukasik Y, Karadag O et al (2017) Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases. Scand J Rheumatol 46:44\u201348. https:\/\/doi.org\/10.3109\/03009742.2016.1167951","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"4636_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.semarthrit.2014.09.004","volume":"44","author":"MM Kostik","year":"2015","unstructured":"Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA et al (2015) Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Semin Arthritis Rheum 44(4):417\u2013422. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.09.004","journal-title":"Semin Arthritis Rheum"},{"key":"4636_CR41","doi-asserted-by":"publisher","first-page":"72\u201378.e3","DOI":"10.1016\/j.jpeds.2017.06.005","volume":"189","author":"F Minoia","year":"2017","unstructured":"Minoia F, Bovis F, Dav\u00ec S, Insalaco A, Lehmberg K, Shenoi K et al (2017) Development and initial validation of the MH score a diagnostic tool that differentiates primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome. J Pediatr 189:72\u201378.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2017.06.005","journal-title":"J Pediatr"},{"key":"4636_CR42","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1093\/rheumatology\/keg074","volume":"42","author":"NM Wulffraat","year":"2003","unstructured":"Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W (2003) Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford) 42:3759. https:\/\/doi.org\/10.1093\/rheumatology\/keg074","journal-title":"Rheumatology (Oxford)"},{"key":"4636_CR43","unstructured":"NHS England Clinical Commissioning Policy Statement: Biologic Therapies for the Treatment of Juvenile Idiopathic Arthritis (JIA). In https:\/\/www.england.nhs.uk\/commissioning\/wp-content\/uploads\/sites\/12\/2015\/10\/e03pd-bio-therapies-jia-oct15.pdf. Last accessed 14th Apr 2020"},{"key":"4636_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA et al (2016) Interleukin1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med 44:275\u2013281. https:\/\/doi.org\/10.1097\/CCM.0000000000001402","journal-title":"Crit Care Med"},{"key":"4636_CR45","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3899\/jrheum.121098","volume":"40","author":"PJ Kahn","year":"2013","unstructured":"Kahn PJ, Cron RQ (2013) Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. J Rheumatol 40:743\u2013744. https:\/\/doi.org\/10.3899\/jrheum.121098","journal-title":"J Rheumatol"},{"issue":"4","key":"4636_CR46","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3899\/jrheum.140288","volume":"42","author":"S Yokota","year":"2015","unstructured":"Yokota S, Itoh Y, Morio T, Sumitomo N, Daimaru K, Minota S (2015) Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis under treatment with tocilizumab. J Rheumatol 42(4):712\u2013722. https:\/\/doi.org\/10.3899\/jrheum.140288(Epub 2015 Feb 15)","journal-title":"J Rheumatol"},{"key":"4636_CR47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.55563\/clinexprheumatol\/r3k9l6","volume":"38","author":"F Ferro","year":"2020","unstructured":"Ferro F, Elefante E, Baldini C, Bartoloni E, Puxeddu I, Talarico R, Mosca M, Bombardieri S (2020) COVID-19: the new challenge for rheumatologists. Clin Exp Rheumatol 38:175\u2013180 (Epub 2020 Mar 24)","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04636-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04636-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04636-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T09:43:15Z","timestamp":1667122995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04636-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4636"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04636-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]},"assertion":[{"value":"26 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors SM, AP, AI, and GTS declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The search algorithm for cited articles is given in Fig.\u00a0.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"No part of the review is copied or published elsewhere.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}